BioLineRx Ltd. BLRX

Latest FY: 2025 Healthcare Biotechnology
Market Price $2.70
Market Cap $7.05B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-95.9% YoY
$1.18M
Full year reported
Net Income ↑129.4% YoY
$6.00M
Net Margin: 508.5%
Free Cash Flow
N/A
FCF Yield: N/A
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: 14.7%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (BLRX)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $-1.4M $-16.5M 0.00%
FY 2017 $-1.7M -25.2% $-25.2M -52.8% 0.00%
FY 2018 $-1.4M +19.6% $-25.6M -1.4% 0.00%
FY 2019 $-0.9M +37.1% $-28.1M -9.8% 0.00%
FY 2020 $-0.8M +2.0% $-22.9M +18.4% 0.00%
FY 2021 +100.0% $-24.8M -8.1% 0.00%
FY 2022 $-29.2M -17.7% 0.00%
FY 2023 $4.8M $1.1M $-49.7M -70.4% 0.00%
FY 2024 $28.9M +502.9% $19.7M $-20.4M +58.9% 0.00%
FY 2025 $1.2M -95.9% $0.9M $6.0M +129.4% 0.00%
$

Valuation

Market Price $2.70
Market Cap $7.05B
Enterprise Value N/A
P/E Ratio N/A
P/B Ratio N/A
FCF Yield N/A
Dividend Yield 0.00%
Shares Outstanding 2,610,814,390
%

Profitability & Margins

Gross Margin 80.51%
Operating Margin 871.78%
Net Margin 508.47%
Return on Equity (ROE) N/A
Return on Assets (ROA) 14.67%
Asset Turnover 0.03x
Revenue 3-Yr CAGR N/A
🛡️

Financial Health & Liquidity

Current Ratio N/A
Cash Ratio N/A
Debt / Equity N/A
Debt / Assets 0.000
Cash & Equivalents N/A
Total Debt N/A
Book Value / Share N/A
💧

Cash Flow Efficiency

Operating Cash Flow N/A
Capital Expenditures (CapEx) $25.00K
Free Cash Flow N/A
OCF / Revenue N/A
FCF / Revenue N/A
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share N/A
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $40.91M
Total Liabilities $17.56M
Stockholders' Equity N/A
Current Assets N/A
Current Liabilities N/A